ArticleScientific reports2025
Machine learning for the prediction of augmented renal clearance (ARC) in patients with sepsis in critical care units.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
This study aims to establish and validate prediction models based on novel machine learning (ML) algorithms for augmented renal clearance (ARC) in critically ill patients with sepsis. Patients with sepsis were extracted from the Medical Information Mart for Intensive Care IV (MIMICIV) database. Seven ML algorithms were applied for model construction. The Shapley Additive Explanations (SHAP) method was used to explore the significant characteristics. Subgroup analysis was conducted to verify the robustness of the model. A total of 2673 septic patients were included in the analysis, of which 518 patients (19.4%) developed ARC within one week after ICU admission. The Extreme Gradient Boosting (XGBoost) model had the best predictive performance (AUC: 0.841) with the highest balanced accuracy (0.778) and the second-highest NPV (0.950). The maximum creatinine level, maximum blood urea nitrogen level, minimum creatinine level, and history of renal disease were found to be the four most significant parameters through SHAP analysis. The AUCs were higher than 0.75 in predicting ARC through subgroup analysis. The XGBoost ML prediction model might help clinicians to predict the onset of ARC early among septic patients and make timely dose adjustments to avoid therapeutic failure.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.